Latest Happenings

Enhanced Penetrative siRNA Delivery by a Nanodiamond Drug Delivery Platform Against Hepatocellular Carcinoma 3D Models. (Nanoscale, Oct 2021)

Authors Jingru Xu 1 2, Mengjie Gu 1 2, Lissa Hooi 2, Tan Boon Toh 3, Dexter Kai Hao Thng 2, Jhin Jieh Lim 2, Edward Kai-Hua Chow 1 2 3 4 5 6 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore. csikce@nus.edu.sg. 2Department of Pharmacology, […]

Enhanced Penetrative siRNA Delivery by a Nanodiamond Drug Delivery Platform Against Hepatocellular Carcinoma 3D Models. (Nanoscale, Oct 2021) Read More »

Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer. (Genome Med, Oct 2021)

Authors Taotao Sheng # 1 2, Shamaine Wei Ting Ho # 2 3, Wen Fong Ooi 4, Chang Xu 2 3, Manjie Xing 2 4, Nisha Padmanabhan 2, Kie Kyon Huang 2, Lijia Ma 5, Mohana Ray 5, Yu Amanda Guo 6, Ngak Leng Sim 6, Chukwuemeka George Anene-Nzelu 7 8 9 10, Mei Mei Chang 6, Milad Razavi-Mohseni 11, Michael A Beer 11, Roger Sik Yin Foo 7 8, Raghav Sundar 2 12, Yiong

Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer. (Genome Med, Oct 2021) Read More »

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021)

Kar-Tong Tan 1 2 3, Ling-Wen Ding 4, Chan-Shuo Wu 1, Daniel G Tenen 5 6, Henry Yang 5 7 Affiliations 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. 2Biological and Biomedical Sciences Program, Division of Medical Sciences, Harvard Medical

Repurposing RNA Sequencing for Discovery of RNA Modifications in Clinical Cohorts. (Sci Adv, Aug 2021) Read More »

Determinants of Response to Daratumumab in Epstein-Barr Virus-Positive Natural Killer and T-Cell Lymphoma. (J Immunother Cancer, Jul 2021)

Nurulhuda Mustafa 1 2, Adina Huey Fang Nee 2, Jing Yuan Chooi 3, Sabrina Hui Min Toh 2, Tae-Hoon Chung 2, Viknesvaran Selvarajan 4, Shuangyi Fan 4, Siok Bian Ng 2 4 5, Michelle Poon 6, Esther Chan 6, Joanne Lee 6, Yen Lin Chee 6, Anand D Jeyasekharan 2 6, Longen Zhou 7, Jennifer Yang 7, Wee Joo Chng 3 2 6 Affiliations 1Department of Medicine,

Determinants of Response to Daratumumab in Epstein-Barr Virus-Positive Natural Killer and T-Cell Lymphoma. (J Immunother Cancer, Jul 2021) Read More »